SCHEMBL6428649

SCHEMBL6428649

Cn1sc(=O)n(-c2cc(-c3ccccc3)on2)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 11/20 0.53
GSK3B P49841 11/20 0.53
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 6/20 0.41
RAB9A P51151 6/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NOTUM Q6P988 1/20 0.41
MEN1 O00255 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426953 0.74 GSK3A (0.41) GSK3AGSK3BALDH1A1NPC1RAB9A
SCHEMBL6428260 0.71 GSK3B (0.80) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL3384007 0.70 GSK3B (1.00) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL6032840 0.65 CHRNA7 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL6427982 0.63 GSK3A (0.69) GSK3AGSK3BCCNB2CDK1CCNB1
SCHEMBL354607 0.63 RAB9A (0.61) ALDH1A1NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL2737273 0.62 RAB9A (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL7221639 0.62 RAB9A (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL13876157 0.62 SLC6A2 (0.56) ALDH1A1NPC1RAB9ASMN1; SMN2NOTUM
SCHEMBL10545373 0.61 ALDH1A1 (0.73) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed